ARCHIVES

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

NCABP “Anyone With Same Facts Would Have Come To Same Conclusion

October 28, 1994

In Brief: NIH Budget Cut Being Considered, Threatening NCI’s Plan For Reaching Year 2000 Goals

December 13, 1984

In Brief: Proposed Drug Act Revisions Would Provide Quick Approval Of “Breakthroughs,” IND_NDA Changes

March 24, 1978

Cancer Funding To Defense Dept. Is Threat To National Cancer Program, Broder Says

March 5, 1993

In Brief: Illinois Comprehensive Center Core Grant Approved, Probably Will Be Funded in FY 79

September 29, 1978

Abbott To Supply Quest With Immunoassay Tests.

September 29, 2000